Introduction
Sexually transmitted diseases represent a major public health problem worldwide, and the advent and increase of human immunodeficiency virus (HIV) during the last decade has highlighted the importance of infections spread by the sexual route. 1 In most developing countries, the incidence and prevalence of sexually transmitted infections (STIs) may be 20 times higher than those in developed countries. 2 Viral STIs are incurable and may be infectious even when symptoms are not present. 3 Chronic infections with HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) are major public health problems, 4 since they are responsible for AIDS (HIV) and cirrhosis of the liver and hepatocellular carcinoma (HBV and HCV). Herpes simplex virus 2 (HSV-2) is now the most common cause of genital ulceration among the sexually transmitted diseases. Methods: A community-based cross-sectional survey was carried out in the tribal population of Jabalpur district. Blood samples were drawn from 326 patients with sexually transmitted infections (STIs) and 526 randomly selected adults. These were tested for HIV, HBV, HCV, and HSV-2 using commercial ELISA kits. Results: The prevalence of IgG antibodies to HSV-2 was 20.8% in STI patients compared to 12.4% in the general population. The HBV carriage rate was 3.4% in STI patients against 2.9% in the general population. HCV prevalence was 3.9% in STI patients and 4.6% in the general population. No HIV infection was found in the study population. Conclusions: In view of the high prevalence of viral STIs in the tribal community of Central India, there is a need to strengthen the STI control program in this under-privileged group. # 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
We conducted this study in the tribal population of Central India to determine the seroprevalence of sexually transmitted viruses, namely, HIV, HBV, and HSV-2. In addition, we also screened the population for HCV.
Methods
This community-based study was carried out at the Regional Medical Research Centre for Tribals, Jabalpur from September 2004 to August 2005. Jabalpur is situated at 23010 0 N, 79056 0 E and a mean altitude of 403 meters above sea level. The center is located in the tribal belt of Central India and mainly conducts research on the tribal population. The tribal population is a group of people sharing common cultural and socio-religious beliefs, residing in a particular geographic area and practicing endogamy. They are an underprivileged group of society, having poor access to the health delivery system.
The study population comprised 326 tribal individuals in the age group 15-49 years, attending the camp clinic and having at least one STI. Clinical examination and standard microbiological tests were performed to diagnose the STI. Speculum examination was also performed in female patients. We also studied 526 randomly selected, healthy tribal adults not having an STI from the same area. For this, we enumerated the population (15-49 years of age) of randomly selected study villages. A random sample of 20% was drawn and included in the study. Demographic, sociocultural, and risk behavior information was collected from study individuals. The survey instruments included a precoded questionnaire and were used in the field after pretesting by trained investigators. Written informed consent was obtained from the study individuals before collecting blood samples. Pretest counseling for HIV testing was given. Approximately 5 ml blood was collected by venipuncture. Sera were separated on site by centrifugation, aliquoted and transported to the laboratory maintaining the cold chain. These were stored frozen until tested.
Serum samples were tested for HIV, HBV, HCV, and HSV-2 using commercial ELISA kits. The samples were tested for HIV using World Health Organization (WHO) Strategy II. ELISA was performed using Biotest HIV Tetra ELISA HIV 1 & 2 (Biotest AG, Germany). Sera positive by first ELISA were tested by rapid tests: Immunocomb II Bispot HIV-1/HIV-2 (Orgenetics Ltd, Israel) or Capillus HIV-1/HIV-2 assay (Trinity Biotech, USA). HSV-2 reactivity was studied by using UBI Magiwel enzyme immunoassay. Hepatitis B surface antigen was detected using the commercially available ELISA test Hepalisa (J Mitra). anti-HCV antibodies were tested using Microlisa (J Mitra). An internal quality check was done by retesting all positive and 5% negative samples.
Data were entered in Microsoft Excel. The Chi-square test was used as the test of significance; 95% confidence intervals were calculated. The study was approved by the institutional ethics committee of the center.
Results and discussion
We studied 852 serum samples from two different groups from the tribal population of Jabalpur district. The first group constituted 326 STI patients (117 male and 209 female). The second group consisted of 526 age-and sex-matched healthy tribal individuals (274 male and 252 female) selected randomly from tribal villages by house-to-house survey. All the surveyed villages are predominantly inhabited by the Gond tribal population.
The prevalence of IgG antibodies to HSV-2 was 20.8% in STI patients compared to 12.4% in the general population. The difference was statistically significant (Chi-square = 11.04, p < 0.001). The HSV-2 reactivity in males was 11.9% in STI patients and 7.3% in the general population. This difference was not statistically significant (Chi-square = 2.24, p > 0.05). In female STI patients, HSV-2 reactivity was 25.8%, while in females selected at random, it was 17.9% (Table 1) . This difference was statistically significant (Chi-square = 4.31, p < 0.05). In a study carried out in Mysore, India, a seropositivity of 11.3% was seen among young married women. 6 Similarly, a study carried out in Bangladesh showed a prevalence of 7.9% to 15.4% in different groups. 7 The results are similar to those obtained in a Korean study, which showed a prevalence of 21.9% in STI clinic attendees. 3 A study conducted among women attending a genitourinary medicine clinic in London 8 showed a prevalence of 26%, while a study carried out in bar and hotel workers of Tanzania 9 showed HSV-2 prevalence of 56.3%. A study carried out in South India showed a prevalence of 1.2% in the general population. 10 The HBV carriage rate was 3.4% in STI patients, against 2.9% in the general population. This difference was not statistically significant (Chi-square = 0.18, p > 0.05). Studies carried out in STI patients in other parts of India have shown HBV carriage rates of 6.2% in Maharashtra, 11 2.9% in North India, 4 and 25.9% in South India.
12
The anti-HCV prevalence was higher in the general population (4.6%) than in the STI patients (3.9%). However, Table 1 Prevalence of HBV carriage, HIV infection, anti-HCV antibodies, and anti-HSV-2 antibodies in the study groups Study population Gender HBsAg n (%) (95% C.I.)
anti-HCV n (%) (95% C.I.)
anti-HSV-2 n (%) (95% C.I.)
anti-HIV n (%) (95% C.I.)
STI patients Male (n = 117) 5 (4.3) (1.5-9) 7 (6.0) (2.6-11.2) 14 (12.0) (6.9-18.6) 0 (0) (0-2.5) Female (n = 209) 6 (2.9) (1.1-5.7) 6 (2.9) (1.1-5. This prevalence is similar to that obtained (4.2%) in a study carried out in Chennai. 12 However, a North Indian study showed a very low (1%) HCV prevalence in STI clinic attendees. 4 The prevalences of anti-HSV-2 and HBsAg were higher in STI patients as compared to the general population. This situation was reversed in the case of anti-HCV antibodies. A possible reason could be that the role of a sexual route in the transmission of HBV and HSV-2 is proven, while it remains controversial in the case of HCV.
13 Table 2 shows the prevalence of the infections by age and sex. All the infections were more common in the 15-24 years age group. Females in this age group showed HSV-2 reactivity of 55.6%.
Among the STI patients, three were infected with both HBV and HCV, while four were infected with both HBV and HSV-2. In the general population, three individuals had HBV and HSV-2 infections, while one had HCV and HSV-2 infections. No individual had all the three infections.
No HIV infection was found in the study population. The reason for this could be that this population belongs to the tribal belt of Central India where there is lack of big industry, urbanization, and designated areas for commercial sex workers.
14 Further, there are no reports of intravenous drug abuse or homo/bisexuality, important predisposing factors for acquiring the infection.
This study shows the presence of various viral STIs, especially HSV-2, in the tribal community of Central India. Although the viral STIs are incurable, their prevalence in the community reflects the degree of risk for STIs. In view of the high prevalence of viral STIs in the tribal community of Central India, there is a need to strengthen the STI control program in this under-privileged group. Sexually transmitted viruses in Central India
